Deutsch | English | North America

Investor Relations

Welcome to investor relations!

Elexxion, which was founded in 2002 in Radolfzell, is an innovative medical engineering company that specializes in developing, manufacturing and selling dental laser systems. Elexxion's products are technologically advanced and extremely user-friendly. With the delos product line, elexxion currently offers an innovative hybrid solution involving high-performance diodes und Er:YAG lasers. Over the next few years, sales will be continued to be pushed in Europe and the US.

It is important for us to have open dialogs with analysts, investors, journalists and (potential) customers.

This section contains information about our public offering on the open market, including the Entry Standard.

German securities code (WKN): A0KFKH
ISIN: DE000A0KFKH0 (International Securities Identification Number)
Ticker symbol: E8X
Trading segment: Open Market
Transparency standard: Entry Standard
Issuing bank: VEM Aktienbank AG
Issuing procedure: IPO
Industry: Medical engineering
Stock class: Non-par value bearer shares of common stock (no-par shares)
Number of shares from the capital increase: Up to 800,000 certificates
Capital stock (following the capital increase): Up to EUR 4,200,000
Entitlement to dividends: Complete entitlement to a share of the profits starting August 3, 2006
Investing period: October 20-26, 2006 2 PM
Price range: EUR 4.00-5.50
Initial listing: October 31, 2006

Lockup agreement

The existing shareholders have issued the VEM Aktienbank AG with a commitment statement according to which the existing shareholders promise to, among other things, not sell shares on or off market directly or indirectly for a period of 12 months as of the initial listing of the company's stock. Sales during this period are only permitted given VEM Aktienbank AG's approval.

We welcome any questions or comments you may have. Please do not hesitate to contact us either by phone or using the form below.

We look forward to hearing from you!